Journal
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
Volume 52, Issue 4, Pages 486-488Publisher
WILEY-LISS
DOI: 10.1002/ccd.1108
Keywords
abciximab; thrombocytopenia; heparin
Categories
Ask authors/readers for more resources
Acute thrombocytopenia associated with abciximab therapy has been well described, although the exact mechanism remains obscure. We report a case of delayed severe thrombocytopenia associated with abciximab therapy for percutaneous coronary intervention that occurred following hospital discharge. The detection of this phenomenon is important as it may portend heightened risk for severe or profound thrombocytopenia on subsequent reexposure to abciximab therapy. (C) 2001 Wiley-Liss, Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available